Home
Contact Us
Aggregated China Business Blogs
2021-01-28
Guosen Securities maintains Tiger Pharma's buy rating: the main business continues to recover and non-recurring returns are relatively high
Aggregated Source:
Caishen.Co
Caishen.Co delivers
Primary Data for China`s Secondary Investment and Stock Markets
. Full details at
Caishen.Co
.
Original URL:
Click here to visit original article
Copyright
Caishen.Co
Related Posts
Spying Fears Prompt Warning To Dutch Athletes Against Taking Phones, Laptops To Beijing Olympics
Stocks post biggest loss in seven weeks
Why NASA’s Psyche probe is embarking on humanity’s first journey to a metal asteroid
Chinese dream readjusted: Why aspirations dim
Rohde & Schwarz Wins China Mobile’s 2021 5G Frequency Scanner Procurement Project
US and Chinese officials to hold high-level meeting in Switzerland
Growth fails to ease inflation fears
‘He is making the UK a climate villain’: MEPs denounce Sunak’s net zero retreat
Energy price inflation weighs on China
China’s Xinhua News Agency Teams Up With Alibaba In Bid To Transform Itself
SEARCH
Browse News
January 2021
S
M
T
W
T
F
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Dec
Feb »
Useful Sites
China Media Blog
China Legal Blog
China Travel Blog
Caishen.Co
ChinaPulse.com
ZhongjintouX.com